Plasticity-Enhancing Effects of Levodopa Treatment after Stroke

Daniela Talhada(Lund University), Karsten Ruscher(Lund University)

International Journal of Molecular Sciences

September 23, 2021

10.3390/ijms221910226

Cited by 12

Related Papers

Erythropoietin is a paracrine mediator of ischemic tolerance in the brain: evidence from an in vitro model.

|PubMed|2002|452

Erythropoietin Is a Paracrine Mediator of Ischemic Tolerance in the Brain: Evidence from an<i>In Vitro</i>Model

|Journal of Neuroscience|2002|387

MicroRNA-124-loaded nanoparticles increase survival and neuronal differentiation of neural stem cells in vitro but do not contribute to stroke outcome in vivo

|PLoS ONE|2018|44

Preserving cognitive function in patients with Alzheimer's disease: The Alzheimer's disease neuroprotection research initiative (ADNRI)

|Neuroprotection/Neuroprotection (Chichester, England. Print)|2023|23